Renal amyloidosis: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Renal Amyloidosis}} {{CMG}}; {{AE}} ==Overview==" |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Renal | {{Renal amyloidosis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{SHH}} | ||
==Overview== | ==Overview== | ||
==[[Renal amyloidosis overview|Overview]]== | |||
==[[Renal amyloidosis historical perspective|Historical Perspective]]== | |||
==[[Renal amyloidosis classification|Classification]]== | |||
==[[Renal amyloidosis pathophysiology|Pathophysiology]]== | |||
==[[Renal amyloidosis causes|Causes]]== | |||
==[[Renal amyloidosis differential diagnosis|Differentiating Cystic fibrosis from other Diseases]]== | |||
==[[Renal amyloidosis epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Renal amyloidosis risk factors|Risk Factors]]== | |||
==[[Renal amyloidosis screening|Screening]]== | |||
==[[Renal amyloidosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | |||
==Diagnosis== | |||
[[Renal amyloidosis diagnostic study of choice|Diagnostic Study of Choice]] | [[Renal amyloidosis history and symptoms|History and Symptoms]] | [[Renal amyloidosis physical examination|Physical Examination]] | [[Renal amyloidosis laboratory findings|Laboratory Findings]] | [[Renal amyloidosis electrocardiogram|Electrocardiogram]] | [[Renal amyloidosis chest x ray|Chest X Ray]] | [[Renal amyloidosis echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Renal amyloidosis CT|CT]] | [[Renal amyloidosis MRI|MRI]] | [[Renal amyloidosis other imaging findings|Other Imaging Findings]] | [[Renal amyloidosis other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | |||
[[Renal amyloidosis medical therapy|Medical Therapy]] | [[Renal amyloidosis surgery|Surgery]] | [[Renal amyloidosis primary prevention|Primary Prevention]] | [[Renal amyloidosis secondary prevention|Secondary Prevention]] | [[Renal amyloidosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Renal amyloidosis future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
:[[Renal amyloidosis case study one|Case #1]] [[Category:Nephrology]] [[Category:Medicine]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
Revision as of 19:54, 13 June 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cystic fibrosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | Echocardiography or Ultrasound | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies